Risk of residual teratoma after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumor and IGCCCG intermediate/poor prognosis: A multi-institutional retrospective cohort study
Antonelli, L., Ardizzone, D., Ravi, P., Sweeney, C., Bagrodia, A., Mego, M., Douglawi, A., Campanelli Palmer, T., Nazzani, S., Giannatempo, P., Franza, A., Paffenholz, P., Saoud, R., Eggener, S., Ho, M., Oswald, N., Olson, K., Tryakin, A., Naoun, N., Javaud, C., Fizazi, K., Cary, C., Fankhauser, C.D.
Published in European urology open science (Online) (01.11.2022)
Published in European urology open science (Online) (01.11.2022)
Get full text
Journal Article